Ledger.Open graph →
SEC Form D · filed July 16, 2024

Scorpion Therapeutics, Inc

Offering
$150.0M
Sold
$125.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Andrew Fedder · Boston, MAExecOleg Nodelman · Boston, MADirectorBrian Piper · Boston, MAExecOtello Stampacchia · Boston, MADirectorAdam Friedman · Somerville, MAExec · DirectorShelley Chu · San Diego, CADirectorDarrin Stuart · Boston, MAExecErica Jackson · Boston, MAExecJean-Francois Formela · Broomfield, CODirectorAmanda Valentino · Boston, MAExecJeffrey Albers · Cambridge, MADirectorSaurabh Saha · Boston, MADirectorArjun Goyal · Boston, MADirectorKeith Flaherty · Boulder, CODirectorMark Chao · Boston, MAExecAndrew Fedder · Boston, MAExecOleg Nodelman · Boston, MADirectorOtello Stampacchia · Boston, MADirectorAdam Friedman · WESTON, FLExec · DirectorShelley Chu · San Diego, CADirectorDarrin Stuart · Boston, MAExecErica Jackson · Boston, MAExecJean-Francois Formela · Cambridge, MADirectorAmanda Valentino · Boston, MAExecJeffrey Albers · Cambridge, MADirectorSaurabh Saha · Boston, MADirectorArjun Goyal · Boston, MADirectorKeith Flaherty · Pembroke, MADirectorMark Chao · Boston, MAExecBrian Piper · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗